Who are Ocean Biomedical, Inc.'s main suppliers?

Ocean Biomedical, Inc. (OCEA) key suppliers include: LONZA-AG, LONZA-SALES-AG, ELKURT. View the full supplier network at chainsifter.com/chain/OCEA.

Who are Ocean Biomedical, Inc.'s major customers?

Ocean Biomedical, Inc. (OCEA) key customers include: AESTHER-HEALTHCARE-SPONSOR-LLC, AHAC-AESTHER-HEALTHCARE-SPONSOR-LLC, AHAC-AHAC-MERGER-SUB-INC, LONZA-AG, NASDAQ-STOCK-MARKET-LLC and 4 more. View the full customer network at chainsifter.com/chain/OCEA.

What sector is Ocean Biomedical, Inc. in?

Ocean Biomedical, Inc. (OCEA) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

OCEA Supply Chain: Ocean Biomedical, Inc. Supplier List & 15 Relationships

3Suppliers

9Customers

3Debt Items

0Related Chains

Ocean Biomedical, Inc. Suppliers

Ticker	Name	Confidence	Evidence
LONZA-AG	LONZA-AG	92%	The Company engaged Lonza pursuant to the development and manufacture of certain products and services along with the assistance in developing the product OCX-253.
LONZA-SALES-AG	LONZA-SALES-AG	92%	The Company engaged Lonza pursuant to the development and manufacture of certain products and services along with the assistance in developing the product OCX-253.
ELKURT	ELKURT	90%	Exclusive License Agreement with Elkurt for Bi-Specific Antibody Anti-CTLA4 On July 31, 2020, we entered into an exclusive license agreement, or the Anti-CTLA4 License Agreement, with Elkurt, for OCX-909.

Ocean Biomedical, Inc. Customers

Ticker	Name	Confidence	Evidence
AESTHER-HEALTHCARE-SPONSOR-LLC	AESTHER-HEALTHCARE-SPONSOR-LLC	62%	such additional Notes at (a) fair value under the fair value option or (b) an amortized cost. Refer to Note 7, Senior Secured Convertible Notes, for further detail on the terms of the Notes and poten…
AHAC-AESTHER-HEALTHCARE-SPONSOR-LLC	AHAC-AESTHER-HEALTHCARE-SPONSOR-LLC	62%	n December 5, 2022 (the “Business Combination Agreement”), by and among, AHAC, AHAC Merger Sub Inc., a wholly-owned subsidiary of AHAC, Aesther Healthcare Sponsor, LLC, Legacy Ocean, and Dr. Chirinje…
AHAC-AHAC-MERGER-SUB-INC	AHAC-AHAC-MERGER-SUB-INC	62%	n December 5, 2022 (the “Business Combination Agreement”), by and among, AHAC, AHAC Merger Sub Inc., a wholly-owned subsidiary of AHAC, Aesther Healthcare Sponsor, LLC, Legacy Ocean, and Dr. Chirinje…
LONZA-AG	LONZA-AG	62%	he Company calls the IPO Warrants for redemption as described above, its management will have the option to require all holders that wish to exercise warrants to do so on a “cashless basis.” In such …
NASDAQ-STOCK-MARKET-LLC	NASDAQ-STOCK-MARKET-LLC	62%	and other fees, which Legacy Ocean stockholders received in the form of shares of common stock of the Company (the consummation of the business combination and other transactions contemplated by the …
SECOND-STREET-CAPITAL-LLC	SECOND-STREET-CAPITAL-LLC	62%	such additional Notes at (a) fair value under the fair value option or (b) an amortized cost. Refer to Note 7, Senior Secured Convertible Notes, for further detail on the terms of the Notes and poten…
UPON-CLOSING-AHAC-MERGER-SUB-INC	UPON-CLOSING-AHAC-MERGER-SUB-INC	62%	n December 5, 2022 (the “Business Combination Agreement”), by and among, AHAC, AHAC Merger Sub Inc., a wholly-owned subsidiary of AHAC, Aesther Healthcare Sponsor, LLC, Legacy Ocean, and Dr. Chirinje…
VELLAR-OPPORTUNITY-FUND-SPV-LLC	VELLAR-OPPORTUNITY-FUND-SPV-LLC	62%	director or officer, disputes could arise between us and our subsidiary’s partners regarding a conflict of interest. These partners also may disagree with the amount and quality of resources that our…
WHITE-LION-CAPITAL-LLC	WHITE-LION-CAPITAL-LLC	62%	director or officer, disputes could arise between us and our subsidiary’s partners regarding a conflict of interest. These partners also may disagree with the amount and quality of resources that our…

Ocean Biomedical, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
OCEA-DEBT	Debt stack $15.4M	90%	Market cache reports total debt of $15.4M.
OCEA-DEBT-11481	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2024-11-22.
OCEA-DEBT-11480	Warrants outstanding: 10	90%	xbrl warrant detail from xbrl 2023-12-31.

Ocean Biomedical, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Ocean Biomedical, Inc..

Ocean Biomedical, Inc. Ownership

Holder	Name	Confidence	Evidence
OCEA-OWNER-BARCLAYS-PLC	BARCLAYS PLC	90%	13F overlay lists BARCLAYS PLC as top holder; 2 tracked holders.

Ocean Biomedical, Inc. Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.

Ocean Biomedical, Inc. Supply Chain